Alamar Biosciences, Inc. (California) (ALMR)
32.74
-1.50
(-4.38%)
USD |
NASDAQ |
Aug 24, 16:00
32.74
0.00 (0.00%)
After-Hours: 20:00
Alamar Biosciences Debt to Equity Ratio : 0.1643 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1643 |
| Date | Value |
|---|---|
| March 31, 2026 | -1.912 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| 10X Genomics, Inc. | 0.0954 |
| Personalis, Inc. | 0.1616 |
| Twist Bioscience Corp. | 0.21 |
| Adaptive Biotechnologies Corp. | 2.872 |
| Champions Oncology, Inc. | 1.167 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 390.98M |
| Total Liabilities (Quarterly) | 78.12M |
| Shareholders Equity (Quarterly) | 312.86M |
| Current Ratio | 11.85 |
| Net Debt Paydown Yield | 0.83% |